Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The actuator, the cable system, the core just to name a few.
Wow, u actually need someone to explain it to you, pathetic.
#uninformed
#clueless
#noclue
Remember he believes IREP IS BEING USED in ENOS.
Yes u r wrong
ISRG says that with all the multi port systems entering market over next couple of years that single port technology will be the primary driver of growth in the future as well as enhanced patient benefits. ISRG said to expect significant investment in Single port technology especially along IP.
word on the street is there are some companies that are ready to pounce on Titan if Medtronic provides the slightest opening. I am fully expecting that if Medtronic makes a low offer then several other offers will be coming in. good thing is that any offer will have to be voted on when Titan decides to be acquired.
If Medtronic offers a BO of $2B (extremely low offer) - that will be announced to the public and a due diligence phase will ensue (30-60 days) ending in a vote on that offer by shareholders. I would fully expect that one of these other companies would make a better offer then Medtronic which would follow the same process. Nothing wrong with a good old fashion bidding war to drive up value - that would probably put final BO in the $4-6B range BUT IF one of them is ISRG then we are well north of $6B BO.
I don't expect Medtronic to leave anyone else an opening based on what Martha says about how Surgical Robotics is priority one and the future of Medtronic but IF HE DOES, the bidding war will be great for shareholders.
Any medical device company that wants to be relevant in surgical robotics and wants to compete with ISRG will need:
Multi-port
single port
Endoluminal
Everyone familiar w this space knows the value in single port since multi port and endoluminal are a dime a dozen platforms.
Btw, steak (cow) cost more then milk
Rumor has it that becton Dickinson wanted Titans IP and single port platform but has to settle for the minor leagues and vicarious surgical.
Ur spot on so what is their motive…..
End of the day check in, after a blood bath in the market today, let’s see- TMDI closes UP! $1.71 - Further away from $1.20. Today would have been ideal to drive it down to $1.50s.
Milestone 4 just around the corner. Another lost day for shorters, bunch of helens. Couldn’t put it any better on a silver platter for them and still can’t deliver - oh vey.
Obviously the daily back and forth is really pointless but imagine if we vented our frustration with this stock to people we know - probably wouldn't end well. So I started thinking about Milestone 4. Milestone 4 is due at the end of Sept. So b/t now and Sept 4th, there will be daily back and forth and its all just background noise. Shorters will back their positions and longs will posit for theirs with no impact either way.
So back to Milestone 4. One thing that we can agree on is that if Milestone 4 is not delivered (the prototype) then its a problem (and makes option 5 - not really an option). So when Milestone 4 is hit and Titan announces it and receives payment what are the next options.
Option 1. Titan receives money, pays off loan and has a Single Port Surgical robotic platform ready for Regulatory Submittal. They decide to go it alone.
Option 2. Medtronic buys out Titan immediately for one lump sum of money (its pretty clear that the BO range projections on this board have an extremely wide spread)
Option 3. Titan and Medtronic enter into another agreement (similar to Mazor deal) where Medtronic takes an equity stake and helps Titan thru human clinical trials, regulatory process and commercialization process.
Option 4. Another player comes in and makes an extremely attractive offer to buy ENOS, Entire Intellectual property portfolio and the world class R&D team.
Option 5. Titan decides to license IP and know how (consistent revenue stream)to other companies eager to get into Surgical robotic space, continues to crank out patents and still has a Single Port Surgical Robotic platform.
When prototype is delivered, I lean towards Option 3, it makes the most sense from both parties and the most logical. It will allow Medtronic to make the ultimate commitment to surgical robotics and Titan and deliver surgical robotic platforms that will be an alternative to ISRG and quite frankly a better platform. Also, acquiring the Single Port platform prevents another company from coming in and acquiring it(some argue the Medtronic can just develop a single port in house but Titan would be a prime competitor with no patent infringement - quite attractive to a JNJ, ISRG, CMR, Stryker, Olympus, etc).
Option 3 would allow Medtronic to collect all the clinical data and studies from ENOS to help in their upstream and downstream marketing. It would also allow them to get in early to help set up manufacturing, supply chain and logistics so when roll out happens its seamless (unlike the Mazor acquistion).
Option 3 would help them tremendously with the HUGO rollout b/c as they speak to CEOs and CIOs of health system, its quite an attractive package to talk about multi-port, single port and endoluminal ALONG with all of Medtronic's other business with their system/facilities.
Option 3 would allow them to move with speed thru the clinical and regulatory process b/c they would be sponsoring Titan and allow Titan to run point with assistance from Medtronic (especially b/c Medtronic will be coming off the heels of their own clinical trials across facilities where the road has been paved). Hospitals and clinicians would be familiar with the shared IP in the systems (i.e hand pieces, ergonomic physician station, etc)
I am hoping for Option 3 b/c I believe as a shareholder that is the best option for my return on investment. Options 1, 2, 4 and 5 all will lead to appreciation but maybe not at the rate of return Option 3 would.
It will be fascinating to say the least and I know every single person who comes on this board is wondering what Option will it be.
Wow, shorters threw everything they had at it today and only got it down to $1.68. Still a long, long way to $1.20. As I said, it will be at or above $1.70 by Friday.
Medtronic is moving w SPEED right now. And shorters are moving like molasses.
$1.20 Weeeeeelllllll………. We’re waiting! LMAO.
Medtronic's Geoff Murtha - "MOVE WITH SPEED"
https://fortune.com/videos/watch/Medtronic-Says-PostPandemic-Business-is-Coming-Back-Strong-/be604606-7e93-447f-9497-ae2ddc307edd
Medtronic's speed right now is concerning to ISRG b/c after Milestone 4 Medtronic will move with speed in Surgical Robotics
of course its a pipedream for ISRG b/c Medtronic has partnered with Titan and will buyout Titan.
Of course, you beleive that Trixie and Vicarious are the gold standard of surgical robotics so what does that say about your knowledge base about surgical robotics.
hang in there IREP19, it will all be over soon.
ISRG should make an offer for Titan right after Milestone 4, the chatter at ISRG about Titan is fast and furious - time is running out for ISRG.
Some facts to consider, Medtronic is licensing tech and IP (they did not buy the IP and do not own it). Any IP developed during this agreement is CO-OWNED by Titan and Medtronic. There is no way that Medtronic will walk away and allow another entity to come in and acquire Titan and all their IP and then hold that over Medtronic's head. There is no way Medtronic will allow another entity to have control of IP that is being utilized in their platform and allow that entity to employ that tech and IP in their own system. Completely Illogical. Also, the acquirer of Titan can rip up any old agreement and then completely screw Medtronic - again, completely ILLOGICAL.
As for the argument that it doesn't matter they already have it in their system so they don't need Titan, doesn't hold water b/c if they want to compete in the space, they can't let any other big Medtech (esp JNJ or ISRG) to acquire all the IP of Titan and just integrate the game changing IP into their own system which would then render Medtronic's IP and system advantages useless b/c they would have the same IP and advantages. I will say this, if Geoff Murtha ends up letting Titan walk and it is scooped up by another major competitor in that space or worse let the 800 lb gorilla ISRG buy it, it might very well cost him his job. CEO's that make a blunder like that will not last long and Murtha seems to be a guy who is buttoned up and thinking long term. Remember that Murtha says that the future of Medtronic and their #1 priority is Surgical Robotics.
There is a reason ISRG is as dominant as they have been is b/c they have IP and no one was able to crack thru it until the IP started expiring. Imagine if ISRG didn't lock down their IP, they would not have become the giant in surgical robotics that they have become. All that points to the importance of anyone getting into this space to lock down IP - Medtronic will/should do the same.
Uh-oh, Titan is up in premarket!!! $1.20 getting smaller and smaller in the rearview mirror.
ISRG is very concerned right now about Titan and Medtronic. They do not want Medtronic to get ENOS. it will be a devastating blow to ISRG’s future growth AND THEY KNOW IT.
ISRG is very interested in the snake arm technology - they believe that it is far superior then their wristed/elbow single port tech. Titan medical OWNS THE SNAKE ARM TECHNOLOGY. Its part of their impressive 170 patents along with their world class R&D team.
I don't even think I will sell if this gets down to $1.55 anymore (no chance it will be some are holding out hope it will get back to that and possibly $1.20)
End of the day check - TMDI is now further away from $1.20 then when the day started. Boy, oh boy. The cat must be out of the bag that ISRG is has a keen interest in Titan Medical but Medtronic is moving too quickly and will not provide any oppty for ISRG.
Up on the open - boy $1.20 looks like it is getting further and further away on the horizon and we are another day closer to Milestone 4 being completed.
Also ISRG is very concerned right now about Titan and Medtronic. They do not want Medtronic to get ENOS. it will be a devastating blow to ISRG’s future growth AND THEY KNOW IT. Medtronic is MOVING VERY QUICKLY now and anything is possible. Remember that the Medtronic/Titan parntership came out of nowhere and that uncertainty about something else happening is defintely cause for me to hold.
But again, I am waiting to see if those that said $1.20 was the PPS target will even get this down to $1.50 first before I do anything.
I would think that before anyone sells to see if this will be taken down towards the $1.20. Obviously it won’t happen overnight but they haven’t moved it at all. So before I sell, I’d like to see them show a set and take it to $1.50 before I would even consider it.
We shall see, it’s on the shorters now but they seem to be running on fumes.
$1.20 Weeeeeellllllll……….. we’re waiting!
That is what the 4th patent in 2 weeks, vicarious is on 8+ years and only has 4 patents TOTAL! And they are valued at $1.1B for nothing at all. Titan is 4-5x more valuable then vicarious- AT A MINIMUM!
ISRG concern is centered around IP. They have had expiring IP and IP will continue to expire into 2022 - they see the Titan IP as a significant threat to their business, especially their future business. They would very much like Titan to try and go it alone but are extremely worried about a medtronic or JNJ owning that IP. In fact, they were completely caught off guard when Medtronic came in and partnered with Titan. Again, they understand that with the IP on multi port expiring and numerous entities entering the surgical robotic space with multi-port, those dime a dozen systems won't have all 3 platforms (multiport, single port and endoluminal) to persuade health systems and hospitals to change from ISRG to say a TRXC or CMR. That is why they are all in on Single Port b/c there is only one serious contender in that space, per them and it is Titan ENOS. They were ok with them trying to go it alone but the Medtronic Partnership and the SPEED at which Medtronic is moving really has them on their heels. ISRG knows full well the breadth of Titan's IP and the advantage it would give Medtronic over them in health systems and hospitals b/c of Medtronic's other business that ISRG has no alternative for.
I would not be the least bit surprised when Milestone 4 is complete and nothing else happens with Medtronic to see ISRG come swooping in to outright buy Titan for the IP alone but they would gladly take ENOS b/c it would wrap up Single Port for ISRG for 20 years. Of Course, Medtronic will not let that happen.
ISRG is very concerned right now about Titan and Medtronic. They do not want Medtronic to get ENOS. it will be a devastating blow to ISRG’s future growth AND THEY KNOW IT.
Just food for thought, if the pps was going to go down to $1.20, wouldn’t it have already started going there? But it hasn’t so what will make it go down? Each day that goes by is another day closer to milestone 4 completion.
If the pps gets down to $1.55 by weeks end , maybe it will keep going down to $1.20 but with the pps staying where it is at, all indicators are pointing to it not going down.
I’m willing to bet that it will be trading at $1.70 or higher by Friday. I will be checking in at the end of every day bt now and Friday to see where pps is.
$1.20. Weeeeellllllll………. We’re STILL WAITING!
No news from Titan, no PRs and the helens can’t take it to $1.50. What’s great is that everyone can time this perfectly. No rush to buy considering it will stay at $1.70 til end of July. No reason to sell bc it won’t go down to $1.20 so can’t buy back at a cheaper price then this.
Was talking to someone at ISRG and their biggest concern to their business is what Titan is bringing to the table. They realize that the dime a dozen multi port systems aren’t a big threat but the SINGLE PORT system and the IP of Titan is very concerning to them. They understand the importance of iron clad IP and they know what Titan has on IP. They believe that Medtronic will will acquire Titan which will complete medtronics offering of multi port, single port and then add the endoluminal.
Remember that some have predicted $1.20 but everyone is still waiting for that. If they can't get it down to $1.58 by weeks end, then I will probably be buying more but I just don't think they have it in them anymore to get it down to $1.20, let alone just a couple of pennies to $1.58. But we shall see, like i keep saying to $1.20 PPS prediction - Weeeeeelllllll........we're waiting Helens.
There has never been a better time then right now to get this down but since it hasn't, it is a great indicator that we are most likely at the bottom ($1.70ish). If we stay here, then I would see PPS appreciation to start late July, early August with it rising to closer to $3-4 by end of Sept. Every indicator is pointing that way with no indicators pointing towards $1.20
For those who believes the market is always right, I give you Lehman Bros, Bear Stearns, Archegos and Bernie Madoff - those are the market and they obviously are clueless.
All I can do is try my best to splain it to you. I think we all agree that MDT eventually acquires TMDI. I believe it will start right after Milestone 4 and it will be in the form of a regulatory and commercial agreement
I also believe that the last thing MDT wants is give the slightest opening to a competitor like JNJ ended up doing and letting Medtronic come right in and steal it from them.
Perhaps an example would be helpful ?
143,075,000 fully diluted (not counting the CDN $22.50's and $18's)
SO let's say another agreement comes and MDT takes an equity position to start at $20M at $2 PPS - THAT would be an add'l 10M issued (now I will be NICE and say only 5M WARRANTS would be attached as a sweetener)...so:
158,075,000 fully diluted with a 10% equity stake from Medtronic they PPS would shoot to $8.70 in 2 days.
*** Then there are certainly more awards/goodies coming, bc with each milestone attainment during this agreement Medtronic would supply cash and keep upping their equity stake (Can't let competition come in). So by Q4 of 2022 - When Titan submits for IDE the PPS will be north of $20/share.
My Point: The farther along it goes - the higher the BO price will be and the more equity stake Medtronic will have. I also firmly believe Titan and Medtronic are tied at the hip. WHY ? Well, the worlds largest medical device maker partnered with Titan for IP and know how and there is no way that they let that walk away to another competitor.
Everyone gets your point that you believe Vicarious and TRXC are the gold standard when it comes to Robotic Surgery. I completely disagree with you on that.
So some believe that vicarious and Trixie are the gold standards in surgical robotics. What! What? For new investors, go look at Trixie and vicarious and if u believe the other posters who are saying that they are the gold standard, sell ur Titan shares or don’t buy Titan shares and put it in Trixie and vicarious. I would never in a million years put a dime in either one but if u believe the knowledge base of the others who believe that TRXC and vicarious (RBOT) are the next gold standard then take ur money and listen to them.
It will be another agreement and the raise will be in the form of Medtronic equity stake. Do u really believe Titan will deliver on everything Medtronic has asked and Medtronic has them raise a big chunk of money from ISRG? NO WAY! No way Medtronic will allow another entity from gaining control of Titan IP that is being utilized in medtronics surgical robotic platforms.
Also upon completion of milestone 4, the loan is paid off and board advisor position is eliminated. All of that opens up a huge blind side that could be very, very problematic and costly for Medtronic if they let that happen.
$1.20 Weeeeeellllllll…….. we’re waiting!
Bc it is only indicated for hernias- one indication!
15mm compared to 25mm - so yes it is smaller incision. But it can’t perform natural orifice like Titan. It doesn’t have a Patented camera system. It’s doesn’t have patented snake arm technology. It doesn’t have wrist roll tech
It doesn’t have 170 patents. It doesn’t have a world class R&D team cranking out patents.
But hey, you think vicarious is the gold standard in robotic surgery. Doesn’t bode well of your understanding of the surgical robotic space and market place.
I’ll take Titan over vicarious every day of the week and twice on Tuesday.
Great point, THERE IS ONLY 2 POSTERS on this Titan medical board claiming that vicarious is the next generation gold standard of surgical robotics- honeycomb777 and Sport19
So I agree that robotic surgery is the future and Medtronic agrees that it is the future!
Sport19 is right that surgical robotic is the future and the future is worth $100’s Billions of dollars in annual revenue.